Back to CVE records
High 8.5Published Aug 20, 2026

CVE-2026-66001Frappe: Improper Authorization in OAuth2 Consent Endpoint

Updated under an hour ago ()

Does this affect you?

It affects frappe. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

Frappe is a full-stack web application framework. Prior to 15.114.0 and 16.26.0, the approve and authorize functions in frappe/integrations/oauth2.py allow the OAuth2 consent flow to proceed without restricting approve to POST, without a csrf_token in frappe/templates/includes/oauth_confirmation.html, and without scoping an active OAuth token check to the requesting client. An attacker can cause an authenticated user to approve an OAuth grant or reuse authorization state for the wrong client, exposing data and permitting actions within the granted scopes. This issue is fixed in versions 15.114.0 and 16.26.0.

CVSS
8.5 HIGH (v4.0, CNA)CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:A/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N
Weakness (CWE)
CWE-352
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
GitHub_M
NVD analysis
Deferred
Record last updated
Aug 25, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
frappe frappe
frappe:frappe (from the name)
before 15.114.0; from 16.0.0-beta.1, < 16.26.0
CNA record

References

  • x-refsource-confirm
  • x-refsource-misc
  • x-refsource-misc
  • x-refsource-misc
  • x-refsource-misc
  • x-refsource-misc
  • x-refsource-misc
  • x-refsource-misc
  • x-refsource-misc

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.